... Executive Commities deferred o7 disapproved 2 proiecots tor CMV colitis (concept shaots 213 + 214)” Also disapproved were three ... catheters; and 5) FDA approval of DHPG for CMV colitis and other disseminated forms of CMV disease. Drugs ...

... York City studied 18 patients with CMV retinitis, CMV colitis (inflammation of the colon), or other CMV gastrointestinal ... to evaluate its benefits for other manifestations of CMV (colitis, encephalitis, etc.). HIVIC-le: This is an experimental ...

... and/or tissue-invasive CMV disease (e.g., CMV colitis, hepatitis, or pneumonia). CMV syndrome is defined better in SOT recipients than ...

... MTP-PE) in later KS 4. DHPG in CMV-colitis--- —-—~ open 5. Alpha interferon in HIV-infected open ...

... a fairly effective agent for the treatment of CMV retinitis and colitis. Unfortunately, as is the case for treatment of most of the infectious complications of AIDS, these responses are temporary. ... the drug in the treatment of CMV retinitis, the NIH is ready to begin a ...

... a fairly effective agent for the treatment of CMV retinitis and colitis. Unfortunately, as is the case for treatment of most of the infectious complications of AIDS, these responses are _ ... of the drug in the treatment of CMV retinitis, the NIH is ready to begin a ...

... to be fairly effective for the treatment of CMV retinitis and colitis, but, unfortunately, the effect is temporary. | Therapies for ...

... lain-Barre syndrome (35). Occasional iso- lation of CMV from the lesions of gastric ulcers and ulcerative colitis intestinal mu- cosa have raised the familiar question ...

... of Guillain-Barré syndrome.*¢ Occa- sional isolation of CMV from the lesions of gastric ulcers and ulcerative colitis P-59 Chapter 5. 7 intestinal mucosa has ...

... quent to HTLV-IIf-related immune suppression, retinitis, colitis, and pneumonia are the most common manifestations of disseminated CMV infection They are often life-threaten- ing The ...